Morgan Stanley Call 103 CVS 20.12.../ DE000MB33TM4 /
02/09/2024 14:21:43 | Chg.-0.002 | Bid17:29:46 | Ask17:29:46 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
0.015EUR | -11.76% | 0.015 Bid Size: 2,000 |
0.040 Ask Size: 2,000 |
CVS HEALTH CORP. D... | 103.00 - | 20/12/2024 | Call |
GlobeNewswire
08/08
Phathom Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire
30/07
Phathom Pharmaceuticals Announces VOQUEZNA® (vonoprazan) Added to CVS Caremark Formularies for Comme...
GlobeNewswire
11/04
Sharecare teams up with Anthem Blue Cross and Blue Shield on Jump Shot for Health initiative to supp...
GlobeNewswire
09/11/2023
Sol-Gel Technologies Reports Third Quarter 2023 Financial Results and Provides Corporate Update
GlobeNewswire
27/09/2023
Payback Time! Community Pharmacists Cheer Class Action Lawsuit Against PBMs to Recoup DIR Fees